Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome.

Mitchell UH.

Neuropsychiatr Dis Treat. 2011;7:251-7. doi: 10.2147/NDT.S19177. Epub 2011 May 6.

2.

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.

Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP.

Sleep Med. 2013 Jul;14(7):675-84. doi: 10.1016/j.sleep.2013.05.016.

3.

A clinical primer on restless legs syndrome: what we know, and what we don't know.

Sethi KD, Mehta SH.

Am J Manag Care. 2012 Aug;18(5 Suppl):S83-8. Review.

4.

Opioids for restless legs syndrome.

de Oliveira CO, Carvalho LB, Carlos K, Conti C, de Oliveira MM, Prado LB, Prado GF.

Cochrane Database Syst Rev. 2016 Jun 29;(6):CD006941. doi: 10.1002/14651858.CD006941.pub2. Review.

PMID:
27355187
5.

[Update on the treatment of restless legs syndrome].

Konno M, Uchiyama M.

Brain Nerve. 2009 May;61(5):549-57. Review. Japanese.

PMID:
19514515
6.

Restless legs syndrome: pathophysiology and modern management.

Nagandla K, De S.

Postgrad Med J. 2013 Jul;89(1053):402-10. doi: 10.1136/postgradmedj-2012-131634. Epub 2013 Mar 22. Review.

PMID:
23524988
7.

Restless legs syndrome.

Ryan M, Slevin JT.

Am J Health Syst Pharm. 2006 Sep 1;63(17):1599-612. Review.

PMID:
16914630
8.

[Restless-legs syndrome].

Karroum E, Konofal E, Arnulf I.

Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):701-21. doi: 10.1016/j.neurol.2008.06.006. Epub 2008 Jul 24. Review. French.

PMID:
18656214
9.

Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.

Stevens MS.

Sleep Med Clin. 2015 Sep;10(3):369-73, xv-xvi. doi: 10.1016/j.jsmc.2015.05.017. Epub 2015 Jul 14. Review.

PMID:
26329447
10.

A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease).

Klingelhoefer L, Cova I, Gupta S, Chaudhuri KR.

Clin Med (Lond). 2014 Oct;14(5):520-4. doi: 10.7861/clinmedicine.14-5-520. Review.

PMID:
25301914
11.

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.

García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ; International Restless Legs Syndrome Study Group.

Sleep Med. 2007 Aug;8(5):520-30. Epub 2007 Jun 1. Erratum in: Sleep Med. 2007 Nov;8(7-8):788. Earley, Christopher J [added].

PMID:
17544323
12.

Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.

García-Borreguero D.

Sleep Med Clin. 2015 Sep;10(3):287-92, xiii. doi: 10.1016/j.jsmc.2015.05.020. Epub 2015 Jul 17. Review.

PMID:
26329438
13.

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.

Garcia-Borreguero D, Benitez A, Kohnen R, Allen R.

Postgrad Med. 2015;127(7):716-25. doi: 10.1080/00325481.2015.1058140. Epub 2015 Jun 16. Review.

PMID:
26077324
14.

Recognition, diagnosis, and treatment of restless legs syndrome.

Smith JE, Tolson JM.

J Am Acad Nurse Pract. 2008 Aug;20(8):396-401. doi: 10.1111/j.1745-7599.2008.00337.x. Review.

PMID:
18786013
15.

Restless legs syndrome. How to provide symptom relief with drug and nondrug therapies.

Paulson GW.

Geriatrics. 2000 Apr;55(4):35-8, 43-4, 47-8. Review.

PMID:
10771701
16.

Pharmacotherapy for restless legs syndrome.

Ferini-Strambi L, Marelli S.

Expert Opin Pharmacother. 2014 Jun;15(8):1127-38. doi: 10.1517/14656566.2014.908850. Epub 2014 Apr 19. Review.

PMID:
24745717
17.

From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.

Bogan RK.

Clin Ther. 2014 Mar 1;36(3):436-55. doi: 10.1016/j.clinthera.2014.01.021. Review.

18.

Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.

Mackie S, Winkelman JW.

CNS Drugs. 2015 May;29(5):351-7. doi: 10.1007/s40263-015-0250-2. Review.

PMID:
26045290
19.

Management of restless legs syndrome in patients on dialysis.

Molnar MZ, Novak M, Mucsi I.

Drugs. 2006;66(5):607-24. Review.

PMID:
16620140
20.

Interventions for chronic kidney disease-associated restless legs syndrome.

Gopaluni S, Sherif M, Ahmadouk NA.

Cochrane Database Syst Rev. 2016 Nov 7;11:CD010690. Review.

PMID:
27819409

Supplemental Content

Support Center